The price, which is confidential and was negotiated for a maximum of 300 huge number of doses, is slightly less than the $19.50 per shot the United States agreed to buy a very first shipment of 100 million doses of the same vaccine, in series with what Reuters reported in November.
The EU booklet dated Nov. eighteen was circulated internally right after the EU announced its supply deal with Pfizer and its German partner BioNTech on Nov. 11.
The EU drug regulator is actually anticipated to determine on Monday on acceptance for the Pfizer vaccine following the shot was authorised in a number of countries, like Britain as well as the United States.
On Thursday Belgian declare secretary with the spending budget Eva De Bleeker released on Twitter a dining room table with price tags Belgium would spend pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the article shortly after publishing.
In this dinner table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) a dose, top many to think this was the total price agreed by way of the EU.
Other vaccines in the table were also shown with prices lower than rates disclosed by EU sources.
“There is surely a complete fee and a price upon delivery,” an EU official required in talks with vaccine makers told Reuters when directed to clarify the difference between the Belgian and EU prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted costs were still partial.
Underneath EU advanced purchase deals for COVID 19 vaccines, the bloc agrees upfront payments with business enterprises to secure doses before they are approved. Following approvals, EU governments are able to pay the rest to buy reserved doses.
The EU has not revealed the upfront payment agreed with Pfizer.
Nevertheless, it said in October which it paid about 1 billion euros found in downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with an additional 1.45 billion euros budgeted for initial payments to Pfizer-BioNTech, Curevac and Moderna.
It’s since agreed supply deals with all 6 organizations and it is negotiating a seventh arrangement with Novavax.